Difference between revisions of "Part:BBa K5302001"
(3 intermediate revisions by one other user not shown) | |||
Line 3: | Line 3: | ||
<partinfo>BBa_K5302001 short</partinfo> | <partinfo>BBa_K5302001 short</partinfo> | ||
− | 8IIU is an anti-VEGF nanobody, and it has 2 chains, chainA sequence: mdvqlvesgg glvqpggslr lscaasgrtf ssysmgwfrq apgkerefvv aiskggykyd avslegrfti srdnakntvy lqinslrped tavyycassr aygssrlrla dtyeywgqgt lvtvss. chainB sequence:mdvqlvesgg glvqpggslr lscaasgrtf ssysmgwfrq apgkerefvv aiskggyky avslegrfti srdnakntvy lqinslrped tavyycassr aygssrlrla dtyeywgqgt lvtvss. These two chains all show great affinity with VEGF, we used pBBR plasmid as a backbone and transfered 8IIU into Escherichia coli Nissle 1917, and finally succeeded in expressing 8IIU. | + | This year, the USTC iGEM team has utilized the competitive binding of vascular endothelial growth factor (VEGF) to develop a targeted bacterial therapy for solid tumors. Our quest for the optimal VEGF-binding protein(or peptide) led us to an in-depth exploration of proteins structurally akin to the vascular endothelial growth factor receptor (VEGFR), which we have named VEGFR-like.8IIU is an anti-VEGF nanobody, and it has 2 chains, chainA sequence: mdvqlvesgg glvqpggslr lscaasgrtf ssysmgwfrq apgkerefvv aiskggykyd avslegrfti srdnakntvy lqinslrped tavyycassr aygssrlrla dtyeywgqgt lvtvss. chainB sequence:mdvqlvesgg glvqpggslr lscaasgrtf ssysmgwfrq apgkerefvv aiskggyky avslegrfti srdnakntvy lqinslrped tavyycassr aygssrlrla dtyeywgqgt lvtvss. These two chains all show great affinity with VEGF, we used pBBR plasmid as a backbone and transfered 8IIU into Escherichia coli Nissle 1917, and finally succeeded in expressing 8IIU. |
+ | |||
+ | <html> | ||
+ | <div style="text-align:center;"> | ||
+ | <img src="https://static.igem.wiki/teams/5302/images/part-registry-8iiu-1.png" | ||
+ | width="60%" style="display:block; margin:auto;" alt="Jamboree Program" > | ||
+ | <div style="text-align:center;"> | ||
+ | <caption> | ||
+ | <b>Figure 1. </b> 8IIU chainA features, from genbank | ||
+ | </caption> | ||
+ | </div> | ||
+ | </div> | ||
+ | </html> | ||
+ | |||
+ | <html> | ||
+ | <div style="text-align:center;"> | ||
+ | <img src="https://static.igem.wiki/teams/5302/images/part-registry-8iiu-2.png" | ||
+ | width="60%" style="display:block; margin:auto;" alt="Jamboree Program" > | ||
+ | <div style="text-align:center;"> | ||
+ | <caption> | ||
+ | <b>Figure 2. </b> 8IIU chainB features, from genbank | ||
+ | </caption> | ||
+ | </div> | ||
+ | </div> | ||
+ | </html> | ||
+ | |||
+ | <html> | ||
+ | <div style="text-align:center;"> | ||
+ | <img src="https://static.igem.wiki/teams/5302/images/part-registry-8iiu-3.png" | ||
+ | width="60%" style="display:block; margin:auto;" alt="Jamboree Program" > | ||
+ | <div style="text-align:center;"> | ||
+ | <caption> | ||
+ | <b>Figure 3. </b> 8IIU structure, from genbank | ||
+ | </caption> | ||
+ | </div> | ||
+ | </div> | ||
+ | </html> | ||
+ | |||
+ | <html> | ||
+ | <div style="text-align:center;"> | ||
+ | <img src="https://static.igem.wiki/teams/5302/images/part-registry-8iiu-4.png" | ||
+ | width="60%" style="display:block; margin:auto;" alt="Jamboree Program" > | ||
+ | <div style="text-align:center;"> | ||
+ | <caption> | ||
+ | <b>Figure 4. </b> Colony PCR results of pBBR-OmpA-8IIU | ||
+ | </caption> | ||
+ | </div> | ||
+ | </div> | ||
+ | </html> | ||
+ | |||
+ | <html> | ||
+ | <div style="text-align:center;"> | ||
+ | <img src="https://static.igem.wiki/teams/5302/images/part-registry-8iiu-5.png" | ||
+ | width="60%" style="display:block; margin:auto;" alt="Jamboree Program" > | ||
+ | <div style="text-align:center;"> | ||
+ | <caption> | ||
+ | <b>Figure 5. </b> Colony PCR results of pBBR-INP-8IIU (1) | ||
+ | </caption> | ||
+ | </div> | ||
+ | </div> | ||
+ | </html> | ||
+ | |||
+ | <html> | ||
+ | <div style="text-align:center;"> | ||
+ | <img src="https://static.igem.wiki/teams/5302/images/part-registry-8iiu-6.png" | ||
+ | width="60%" style="display:block; margin:auto;" alt="Jamboree Program" > | ||
+ | <div style="text-align:center;"> | ||
+ | <caption> | ||
+ | <b>Figure 6. </b> Colony PCR results of pBBR-INP-8IIU (2) | ||
+ | </caption> | ||
+ | </div> | ||
+ | </div> | ||
+ | </html> | ||
+ | |||
+ | <html> | ||
+ | <div style="text-align:center;"> | ||
+ | <img src="https://static.igem.wiki/teams/5302/images/part-registry-8iiu-7.png" | ||
+ | width="60%" style="display:block; margin:auto;" alt="Jamboree Program" > | ||
+ | <div style="text-align:center;"> | ||
+ | <caption> | ||
+ | <b>Figure 7. </b> Colony PCR results of pBBR-INP-8IIU (3) | ||
+ | </caption> | ||
+ | </div> | ||
+ | </div> | ||
+ | </html> | ||
+ | |||
+ | <html> | ||
+ | <div style="text-align:center;"> | ||
+ | <img src="https://static.igem.wiki/teams/5302/images/part-registry-8iiu-8.png" | ||
+ | width="60%" style="display:block; margin:auto;" alt="Jamboree Program" > | ||
+ | <div style="text-align:center;"> | ||
+ | <caption> | ||
+ | <b>Figure 8. </b> SDS-PAGE analysis of pBBR1MCS-OmpA-8IIU expression in Escherichia coli Nissle 1917 | ||
+ | </caption> | ||
+ | </div> | ||
+ | </div> | ||
+ | </html> | ||
+ | |||
+ | |||
<!-- Add more about the biology of this part here | <!-- Add more about the biology of this part here |
Latest revision as of 16:55, 1 October 2024
8IIU
This year, the USTC iGEM team has utilized the competitive binding of vascular endothelial growth factor (VEGF) to develop a targeted bacterial therapy for solid tumors. Our quest for the optimal VEGF-binding protein(or peptide) led us to an in-depth exploration of proteins structurally akin to the vascular endothelial growth factor receptor (VEGFR), which we have named VEGFR-like.8IIU is an anti-VEGF nanobody, and it has 2 chains, chainA sequence: mdvqlvesgg glvqpggslr lscaasgrtf ssysmgwfrq apgkerefvv aiskggykyd avslegrfti srdnakntvy lqinslrped tavyycassr aygssrlrla dtyeywgqgt lvtvss. chainB sequence:mdvqlvesgg glvqpggslr lscaasgrtf ssysmgwfrq apgkerefvv aiskggyky avslegrfti srdnakntvy lqinslrped tavyycassr aygssrlrla dtyeywgqgt lvtvss. These two chains all show great affinity with VEGF, we used pBBR plasmid as a backbone and transfered 8IIU into Escherichia coli Nissle 1917, and finally succeeded in expressing 8IIU.
Sequence and Features
- 10COMPATIBLE WITH RFC[10]
- 12COMPATIBLE WITH RFC[12]
- 21COMPATIBLE WITH RFC[21]
- 23COMPATIBLE WITH RFC[23]
- 25COMPATIBLE WITH RFC[25]
- 1000COMPATIBLE WITH RFC[1000]